Abstract:Emerging and re-emerging viral pandemics have emerged as a major public health concern. Highly pathogenic coronaviruses, which cause severe respiratory disease, threaten human health and socioeconomic development. Great efforts are being devoted to the development of safe and efficacious therapeutic agents and preventive vaccines to combat them. Nevertheless, the highly mutated virus poses a challenge to drug development and vaccine efficacy, and the use of common immunomodulatory agents lacks specificity. Benefiting from the burgeoning intersection of biological engineering and biotechnology, membrane-derived vesicles have shown superior potential as therapeutics due to their biocompatibility, design flexibility, remarkable bionics, and inherent interaction with phagocytes. The interactions between membrane-derived vesicles, viruses, and the immune system have emerged as a new and promising topic. This review provides insight into considerations for developing innovative antiviral strategies and vaccines against SARS-CoV-2. First, membrane-derived vesicles may provide potential biomimetic decoys with a high affinity for viruses to block virus-receptor interactions for early interruption of infection. Second, membrane-derived vesicles could help achieve a balanced interplay between the virus and the host's innate immunity. Finally, membrane-derived vesicles have revealed numerous possibilities for their employment as vaccines. Membrane-derived vesicles have attracted a considerable amount of interest due to their biocompatibility, design flexibility, remarkable bionics, and inherent interaction with phagocytes. They may provide potential therapeutics to protect individuals from SARS-CoV-2 infection, including blocking of viral entry as biomimetic decoys, achieving a balanced immunoregulation, and improving vaccine efficacy. image

mSphere of Influence: Apoptotic Mimicry and Virus Entry

mSphere of Influence: Understanding Virus-Host Interactions Requires a Multifaceted Approach

mSphere of Influence: Where the Pathogen Proteins Are

mSphere of Influence: MmuPV1—a dual tropic papillomavirus, red herring, or novel insight into HPV pathogenesis

mSphere of Influence: If virulence is energetically costly, how can it be maintained?

mSphere of Influence: Retreading old ground-the beauty in multi-omic data sets

mSphere of Influence: Systemic decoding gene function in Toxoplasma gondii pathogenesis—CRISPR screens and beyond

mSphere of Influence: Experimental Evolution of RNA Viruses

Molecular Mimicry as a Mechanism of Viral Immune Evasion and Autoimmunity

mSphere of Influence: Coordinating effective clearance of bacterial bloodstream infections

mSphere of Influence: Innate Immunity at the Maternal-Fetal Barrier

Investigating Viruses during the Transformation of Molecular Biology

mSphere of Influence: Metabolic redundancies enhance pathogenesis

Viral imitation is the sincerest form of epigenetic flattery

MITAgating Viral Infection

mSphere of Influence: How host genetics impact microbial pathogenesis and treatment of infectious disease

mSphere of Influence: Combining Host and Pathogen Genetics To Disrupt Chronic Infections

A glimpse into viral warfare: decoding the intriguing role of highly pathogenic coronavirus proteins in apoptosis regulation

Apoptosis dysfunction: unravelling the interplay between ZBP1 activation and viral invasion in innate immune responses

Author Response for "from Virus to Immune System: Harnessing Membrane‐derived Vesicles to Fight COVID‐19 by Interacting with Biological Molecules"

Viral Inhibitors Reveal Overlapping Themes In Regulation Of Cell Death And Innate Immunity